We are proud to announce that Hyamax’s monophasic cross – linked hyaluronic acid product line has received EU Medical Device Regulation (MDR) certification. This makes us one of the global high-end aesthetic brands to achieve this prestigious recognition. The MDR certification ensures Hyamax products meet the highest standards for stability, biocompatibility, and clinical efficacy. 

Hyamax’s HA offers 6 different specifications – providing a comprehensive solution that meets various clinical needs with a single, versatile product line.

This breakthrough solidifies Hyamax’s leadership in the high-end medical aesthetics market, as we continue to uphold our philosophy of Leading the Future of Medical Aesthetics, offering safer and more effective beauty solutions worldwide.